Microbiome in Head and Neck Squamous Cell Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity of Colorado, Denver
About this trial
This study aims to determine whether dysbiosis actively contributes to HNSCC and if so, the underlying molecular mechanisms.
Eligibility criteria
Qualifiers
Subjects equal to or above the age of 18.
Patients who are seen and evaluated by a provider within the adult Otolaryngology clinic at the University of Colorado Health.
Patients that present with a diagnosis of OSCC.
An equal number of age-matched patients who are visiting the clinic for reasons other than OSCC diagnoses, as the control group.
Disqualifiers
Subjects under the age of 18 or over the age of 100
Subjects unwilling to particiapte
Trial design
Treatments tested in this trial
- Metagenomic sequencing
- Metabolic analysis
Treatment groups
60 Participants
are divided into 4 treatment groupsSponsors and collaborators
University of Colorado, Denver
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov